PDCD1LG2 and neoplasm: Intriguingly, studies on PD-1-deficient mice showed that PD-L2 could still interact with and convey costimulatory effects to PD-1-/- T cells, raising the hypothesis of a second, costimulatory receptor in tumor microenvironment (TME) (13).